The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells
about
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytesPartial characterization of natural and recombinant human soluble CD23Structure and expression of c-fgr protooncogene mRNA in Epstein-Barr virus converted cell linesThe absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient micePromoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing.Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth.Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cellsMolecular structure of the gene and the 5'-flanking region of the human lymphocyte immunoglobulin E receptor.A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells.Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro.Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line raelEpstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.The role of lactic acid in autocrine B-cell growth stimulationEBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.Surface proteins and glycoproteins of human leucocytes.Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrates isotype regulatory function.The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.CD23 antigen regulation and signaling in chronic lymphocytic leukemia.Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity.Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.
P2860
Q24315666-4BC74890-1C31-4533-A8D3-D638FCD09353Q24528084-3D2E8E33-C8DF-45E9-B458-21F76A766510Q24645714-EC58977B-B4ED-4435-877B-9D99B3365783Q28590703-75142396-794B-4742-B91E-6DA1C2015CB9Q33604108-37FA9947-DE76-485B-B4B6-A99D2858FFD0Q33810690-786133FE-C47F-4A3B-9759-C66AE73454D0Q34302121-4B5F8695-BBE5-44F4-9DA5-6E615E5555A7Q34308504-130865E5-AC25-467C-9061-8C628A9954D1Q34343527-960FBCB7-2706-40B3-8B7C-5D00F32A6253Q34366291-3CC568ED-E143-44C3-B70B-A75048BA0AFAQ34708009-914B0A06-D123-484B-8927-B7C6A4FE40FDQ36015363-41E56F35-A636-499C-B761-C28CE6E757D5Q36361402-43209878-E0BB-45E6-8AB4-BF387118F559Q36371518-9F0EAF48-6990-4E79-8C82-8D743811742FQ36801839-A3DC1BE9-CD69-4B9D-B2B7-3CBDE9C3C5BCQ36808389-3CDCF053-B5C1-4CC5-8B4E-3F64D719C73AQ36829470-91815D12-17E4-4480-8FA2-6BBAF4A68565Q36881880-47A5A935-7C4D-4B20-905B-021463269A52Q37585854-0A6198C4-1ED6-409C-810E-1CBC84CC7322Q37640575-FCF35665-5770-4830-81DF-447F4A1CCA53Q38304806-35D4978F-C128-4824-819E-D7687474DDCEQ39524176-C52F8E44-921B-4255-97A2-1728514D550AQ40108807-93DF14AD-7CE6-4E19-88D2-756B72CBF31AQ40117028-B51271A3-79EB-44E3-B05C-A63CBDD9878DQ40129024-3FFB24EB-1B14-4427-AF02-CEED2461876FQ40377549-CB49335E-044D-4977-B15D-2FE6E13AEE17Q40555242-77F8BF5E-348E-40BF-A579-EB7BB519BEA9Q41019661-9A39CB9E-EDA6-4174-9D38-F01C071CA65AQ41723566-0BB549D9-A6FB-4729-8A86-3EB4D7374031Q42939136-360AF0DD-801D-4D1E-9537-C1CF78B9F1BD
P2860
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
The activation antigen BLAST-2 ...... normal and transformed B cells
@en
type
label
The activation antigen BLAST-2 ...... normal and transformed B cells
@en
prefLabel
The activation antigen BLAST-2 ...... normal and transformed B cells
@en
P2860
P1433
P1476
The activation antigen BLAST-2 ...... normal and transformed B cells
@en
P2093
D A Thorley-Lawson
S Swendeman
P2860
P304
P356
10.1002/J.1460-2075.1987.TB02412.X
P407
P577
1987-06-01T00:00:00Z